FDA Accepted Review Of New Drug Application For Pfizer's (PFE) Tofacitinib
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.75 -0.04 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.79 | 52 Week High | $37.39 | |||
| Open | $29.54 | 52 Week Low | $28.25 | |||
| Day High | $29.86 | P/E | 18.03 | |||
| Day Low | $29.51 | EPS | $1.65 | |||
| Volume | 9,756,048 | |||||
